El Hospital Universitario Arnau de Vilanova es el centro hospitalario de referencia de la sanidad pública de la provincia de Lérida, del Alto Pirineo y Arán y de algunas comarcas de la Franja de Aragón. Su gestión corresponde al Instituto Catalán de la Salud.​ Actualmente dispone de 463 camas.​

During the past decade, Hospital Universitari Arnau de Vilanova conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 56 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 87 clinical trials started and 36 clinical trials were completed. i.e. 41.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitari Arnau de Vilanova" #1 sponsor was "PETHEMA Foundation" with 14 trials, followed by "Hoffmann-La Roche" with 12 trials sponsored, "MedSIR" with 10 trials sponsored, "SOLTI Breast Cancer Research Group" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 182 different institutions and companies that sponsored additional 118 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Arnau de Vilanova" #1 collaborator was "Pfizer" with 8 trials as a collaborator, "Hoffmann-La Roche" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Breast International Group" with 5 trials as a collaborator and "Merck Sharp & Dohme LLC" with 5 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 117 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari Arnau de Vilanova" are "Breast Cancer" (36 trials), "Metastatic Breast Cancer" (16 trials), "Breast Neoplasms" (9 trials), "Multiple Sclerosis" (6 trials) and "Triple Negative Breast Cancer" (6 trials). Many other conditions were trialed in "Hospital Universitari Arnau de Vilanova" in a lesser frequency.

Most popular intervention types in "Hospital Universitari Arnau de Vilanova" are "Drug" (176 trials), "Other" (32 trials), "Procedure" (15 trials), "Device" (13 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Trastuzumab" (15 trials), "Paclitaxel" (12 trials), "Capecitabine" (11 trials) and "Docetaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari Arnau de Vilanova" are 190 trials for "All" genders, 48 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitari Arnau de Vilanova". 2 are not yet recruiting, 48 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 126 completed trials in Hospital Universitari Arnau de Vilanova, 2 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari Arnau de Vilanova, 14 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 26 trials that are defined as “Not Applicable".

Hospital Universitari Arnau de Vilanova has several departments that took part in Clinical trials: "Hospital Universitari Arnau de Vilanova de Lleida; Servicio de Neurología" - 4 trials, "Hospital Universitario Arnau de Vilanova, Servicio de Oncologia" - 2 trials